drugset / Trial / NCT04044079
Vaginal Dinoprostone Versus Vaginal Misoprostol Prior to Diagnostic Office Hysteroscopy in Postmenopausal Patients
RandomizedParallel-groupQuadruple-blindTreatment
Summary
To compare the effectiveness of vaginal dinoprostone and vaginal misoprostol with placebo in minimizing the pain experienced by postmenopausal patients during diagnostic office hysteroscopy and to assess the ease of insertion of hysteroscope as reported by the hysteroscopist.
Timeline
- Start
- 2019-08-20
- Primary completion
- 2020-01-10
- Completion
- 2020-02-10
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Dinoprostone | Other / unclassified | 3 mg | Intrathecal |
| Comparator | Misoprostol | Other / unclassified | 200 ug | Intrathecal |
Indications
No indication recorded.